FIELD: medicine.
SUBSTANCE: invention discloses method, computer-readable medium and system for determination of genetic foetal anomaly, which is aneuploidy. Peripheral blood of pregnant woman is obtained sequence of multiple polynucleotide fragments are matched with chromosomes by comparing with reference genomic sequence of human, depth of coating and GC content chromosomes and chromosome coating depth is compared with approximated depth coating, where difference between them indicates aneuploidy.
EFFECT: presented group of inventions provides effective agents and methods for non-invasive detection of foetal aneuploidy.
13 cl, 21 dwg, 1 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR NON-INVASIVE PRENATAL SCREENING OF FETAL ANEUPLOIDY | 2019 |
|
RU2712175C1 |
NON-INVASIVE DIAGNOSTIC TECHNIQUE FOR FOETAL ANEUPLOIDY BY SEQUENCE ANALYSIS | 2014 |
|
RU2543155C1 |
NON-INVASIVE PRENATAL DIAGNOSIS OF FOETAL ANEUPLOIDY | 2014 |
|
RU2583830C2 |
METHOD FOR NONINVASIVE PRENATAL DIAGNOSTICS OF FETAL ANEUPLOIDY | 2015 |
|
RU2627673C2 |
NONINVASIVE DIAGNOSTIC DNA TEST FOR ANEUPLOIDY DETECTION | 2012 |
|
RU2638456C2 |
METHOD FOR IDENTIFYING FETAL ANEUPLOIDY IN A BLOOD SAMPLE OF THE PREGNANT WOMAN | 2021 |
|
RU2777072C1 |
DIAGNOSTIC TECHNIQUE FOR ANEUPLOIDY BY SEQUENCE ANALYSIS | 2012 |
|
RU2529784C2 |
METHODS AND SYSTEMS FOR DETERMINING WHETHER GENOME IS ABNORMAL | 2011 |
|
RU2599419C2 |
METHOD OF DETERMINING THE SOURCE OF ANEUPLOID CELLS ON THE BLOOD OF A PREGNANT WOMAN | 2016 |
|
RU2674700C2 |
METHOD FOR DETERMINING FOETAL KARYOTYPE OF PREGNANT WOMAN BASED ON SEQUENCING HYBRID READINGS CONSISTING OF SHORT FRAGMENTS OF EXTRACELLULAR DNA | 2019 |
|
RU2717023C1 |
Authors
Dates
2016-07-10—Published
2011-06-29—Filed